SV40 - vervuild poliovaccin met als extra
een apenvirus
Tussen 1954 en 1962 zijn er alleen al in
Amerika 98 miljoen Amerikanen ingeënt met een poliovaccin dat vervuild was met het SV40
virus. Men vermoedt een relatie tussen dit type virus en diverse vormen van kanker omdat
de twee vaak samen aangetroffen worden. Al in 1960 was dit bekend maar men is om
financiële redenen (zoals altijd) nog jaren gewoon doorgegaan met het gebruik van dat
vaccin, ook in Nederland. Voor de mensen die denken dat dit weer zo'n hoax verhaal is,
bekijk dan maar eens even de links op de Amerikaanse overheidssites. Het filmpje laat weer
eens goed zien hoe big pharma met onze belangen om gaat....
Ron
Vaccinatie
- een onderzoek van haar schaduwzijde
Het is algemeen bekend dat miljoenen doses
poliovaccin die tussen 1954 en 1962 werden toegediend het Simian-virus 40 (SV40) bevatte,
dat door veel schrijvers in verband is gebracht met een hoge mate van optreden van kanker,
waaronder kinderleukemie en de soort longkanker die algemeen in verband wordt gebracht met
blootstelling aan asbest. Cecil Fox, die van 1973 tot 1991 een vooraanstaand wetenschapper
was bij het National Institute of Health (een soort Rijksinstituut voor Volksgezondheid),
heeft gezegd dat ‘wanneer je gemalen ingewanden van apen in kinderen injecteert er
allerlei dingen kunnen gebeuren’ (What your Doctor . . ., blz. 145). Op kweekbodems
kunnen virussen verontreinigd raken waardoor vaccins onbekende virussen en bacteriën
kunnen meebrengen die volgens sommige onderzoekers leiden of bijdragen tot
auto-immuunziekten zoals astma, artritis, en diabetes; chronische infecties zoals
bronchitis, oorinfecties en griep; abnormaal schreeuwen en voortdurend huilen van
baby’s; beroerten en shocktoestanden, stuiptrekkingen, epilepsie, ontstekingen van
verschillende delen van de hersenen, en nog vele andere.
Mesothelioma is een vorm van kanker. Het
veroorzaakte door vorige blootstelling aan asbest. Een blootstelling van zo weinig zoals
één of twee maanden kan in mesothelioma 30 of 40 later jaar resulteren. Simian virus 40
(SV40) kan als cofactor in de ontwikkeling van mesothelioma dienst doen.
This stunning censored interview conducted
by medical historian Edward Shorter for WGBH public television (Boston) and Blackwell
Science was cut from The Health Century due to its huge liability--the admission that
Merck drug company vaccines have traditionally been injecting cancer viruses (SV40 and
others) in people worldwide. This segment of In Lies We Trust: The CIA, Hollywood &
Bioterrorism, produced and freely contributed by consumer protector and public health
expert, Dr. Leonard Horowitz, features the world's leading vaccine expert, Dr. Maurice
Hilleman, who explains why Merck's vaccines have spread AIDS, leukemia, and other horrific
plagues worldwide.
Dr. Leonard G. Horowitz is one of
healthcare's most captivating and controversial motivational speakers. He received his
doctorate from Tufts University in 1977, and then was awarded a fellowship in behavioral
research at the University of Rochester. Dr. Horowitz later earned two master's degree,
one in public health from Harvard University, and the other in health education from
Beacon College. http://www.tetrahedron.org/aboutus.html
Lees zeker eens deze paginas !
Simian virus 40
SV40 is an abbreviation for Simian
vacuolating virus 40 or Simian virus 40, a polyomavirus that is found in both monkeys and
humans. Like other polyomaviruses, SV40 is a DNA virus that has the potential to cause
tumors, but most often persists as a latent infection. The virus was first
identified in 1960 in cultures of rhesus monkey kidney cells that were being used to
produce polio vaccine. It was named for the effect it produced on infected green monkey
cells, which developed an unusual number of vacuoles. The complete DNA sequence of the
virus was sequenced by Walter Fiers and his team at the University of Ghent (Belgium) in
1978[1]. The virus is dormant and shows no visible effects in Rhesus monkeys. The virus
has been found in many macaque populations in the wild, where it rarely causes disease.
However, in monkeys that are immunodeficient—due to, for example, infection with
Simian immunodeficiency virus—SV40 acts much like the human JC and BK polyomaviruses,
producing kidney disease and sometimes a demyelinating disease similar to PML. In other
species, particularly hamsters, SV40 causes a variety of tumors, generally sarcomas. In
rats, the oncogenic SV40 Large T-antigen was used to establish a brain tumor model for
PNETs and medulloblastomas. The molecular mechanisms by which the virus reproduces and
alters cell function were previously unknown, and research into SV40 vastly increased
biologists' understanding of gene expression and the regulation of cell growth.
Simian Virus 40 (SV40), a Possible Human Polyomavirus
During the past 4 years, polymerase
chain reaction (PCR) assays have detected DNA sequences related to SV40 (an oncogenic
simian polyomavirus) in a variety of human tissues, especially choroid plexus tumors,
ependymomas, mesotheliomas, and osteosarcomas.. These findings were supported by the
isolation of infectious SV40 from a choroid plexus tumor . Although another paper reported
the failure to detect SV40 DNA in mesotheliomas (9), these studies have reawakened
interest in inadvertent human exposure to SV40 in the late 1950s and early 1960s when
polio and adenovirus vaccines prepared in rhesus monkey cells containing SV40 were used
(10,11). In response to the implications of detecting SV40 DNA in human tumors, the Food
and Drug Administration, National Institutes of Health, National Vaccine Program Office,
and Centers for Disease Control and Prevention sponsored a workshop on SV40 on January
27-28, 1997 at the National Institutes of Health to examine the possibility that SV40 is
an infectious agent in humans.
At a glance: SV40 is a virus found in
some species of monkey. Soon after its discovery in 1960, SV40 was found in polio vaccine.
Over 98 million Americans received one or more doses of polio vaccine during the period
(1955-1963) when some of the vaccine was contaminated with SV40. SV40 has been found in
certain types of human cancers, but it has not been determined that SV40 causes these
cancers. The majority of evidence suggests there is no causal relationship between receipt
of SV40-contaminated vaccine and cancer; however, some research results are conflicting
and more studies are needed.
SV40 contaminated vaccines were
injected into children up until 1963
Upon the discovery that SV40 was an
animal carcinogen that had found its way into the polio vaccines, a new federal law was
passed in 1961 that required that no vaccines contain this virus. However, this law did
not require that SV40 contaminated vaccines be thrown away or that the contaminated seed
material (used to make all polio vaccines for the next four decades) be discarded. As a
result, known SV40 contaminated vaccines were injected into children up until 1963. In
addition, it has been alleged that there have been SV40-contaminated batches of oral polio
vaccine administered to some children until the end of the 1990's.
Simian Virus 40 (SV40:) A
Possible Human Polyomavirus Workshop
And I'd like to summarize our findings
in the following points. One is that SV40 grows well in some human cells types. In cell
types which it does not grow well in, like fibroblast and human embryonic kidney cells,
this slow growth appears to be caused by some function of the SV40 late region, because
when we replace the SV40 late region with the late region from BK virus or RF virus -- a
variant of BK -- we now get rapid growth in human embryonic kidney cells and in
fibroblast. Finally, in fibroblasts then, in human embryonic kidney cells, wild type SV40
produces very small amounts of T-antigen but it produces very large amounts of the capsid
protein, VP1. And in fact, there may be 150 times more VP1 than there is T-antigen. And
this overexpression of the VP1 gene, or the late region, appears to inhibit T-antigen
production.
Simian virus 40 (SV40) T antigen
sequences, were found in 42% of blood and tissue samples from people with non-Hodgkin
lymphoma but found none in samples from people without non-Hodgkin lymphoma or other types
of cancer
Brown F, Lewis AM (eds): Simian virus 40
(SV40): A possible human polyomavirus. Dev Biol Stand. Basel, Karger, 1998, vol 94.
Carbone M, Pass HI, Rizzo P, Marinetti M,
Di Muzio M, Mew DJ, Levine AS, Procopio A. Simian virus 40-like DNA sequences in human
pleural mesothelioma. Oncogene 1994, 9:1781-90.
Carbone M. Simian virus 40 and human
tumors: It is time to study mechanisms. J Cellular Biochemistry 1999, 76: 189-93.
Carroll-Pankhurst C, Engels EA, Strickler
HD, Goedert JJ, Wagner J, Mortimer EA. Thirty-five year mortality following receipt of
SV40-contaminated polio vaccine during the neonatal period. Br J Cancer 2001,
85(9):1295-7.
Cicala C, Pompetti, Carbone M. SV40 induces
mesotheliomas in hamsters. Am J Pathology 1993, 142:1524-33.
De Rienzo A, Tor M, Sterman DH, Aksoy F,
Albelda SM, Testa JR. Detection of SV40 DNA sequences in malignant mesothelioma specimens
from the United States, but not from Turkey. J Cell Biochem 2002; 84(3):455-9.
Eddy BE, Borman GS, Berkeley W, Young RD.
Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc. Soc.
Exp. Biol. (NY) 1961, 107:191-197.
Emri S, Kocagoz T, Olut A, Gungen Y, Mutti
L, Baris YI. Simian virus 40 is not a cofactor in the pathogenesis of of environmentally
induced malignant pleural mesothelioma in Turkey. Anticancer Res 2000; 20(2A):891-894.
Farwell JR, Dohrmann GJ, Marrett LD, Meigs
JW. Effect of SV40 virus contaminated polio vaccine on the incidence and type of CNS
neoplasms in children: a population based study. Trans Am Neurol Assoc 1979, 104:261-264.
Fisher SG, Weber L, Carbone M. Cancer risk
associated with simian virus 40 contaminated polio vaccine. Anticancer Res 1999,
19(3B):2173-2180.
Fraumeni JF, Ederer F, Miller RW. An
evaluation of the carcinogenicity of simian virus 40 in man. J Am Med Assoc 1963,
185:713-718.
Fraumeni JF, Stark CR, Gold E et al. Simian
virus 40 in polio vaccine: follow up of newborn recipients. Science 1970, 167:59-60.
Geissler E, Konzer P, Scherneck S,
Zimmermann W. Sera collected before introduction of contaminated polio vaccine contain
antibodies against SV40. Acta Virologica 1985, 29:420-23.
Geissler E, Staneczek. W. SV40 and human
brain tumors. Archive fur Geschwulstforschung 1988, 58:129-134.
Heinonen OP, Shaprio S, Monson R et al.
Immunization during pregnancy against poliomyelitis and influenza in relation to childhood
malignancy. Int J Epidemiol 1973, 2:229-235.
Horvath LB, Incidence of SV40 virus
neutralizing antibodies in sera of laboratory workers. Acta Microbiol Acad Sci Hung
1965;12(2):201-5.
Jasani B, Cristaudo A, Emri SA, et al.
Association of SV40 with human tumors. Semin Cancer Biol 2001, 11:49-61.
Levine A, Butel J, Dorries K, Goedert J,
Frisque R, Garcea R, Morris A, O’Neill F, Shah K. SV40 as a putative human commensal.
Developments in Biological Standardization 1998, 94:245-69.
Minor PD, Dunn G, Piplin PA. Detection and
growth kinetics of SV40 preparations with different enhancer element copy number. Vaccine
2001 May 14;19(25-26):3457-71.
Mortimer EA, Lepow ML, Gold E, et al.
Long-term Follow-up of persons inadvertently inoculated with SV40 as neonates. Medical
Intelligence 1981, 305:1517-1518.
Newman JS, Baskin GB, Frisque RJ.
Identification of SV40 in brain, kidney and urine of healthy and SIV-infected rhesus
monkeys. J NeuroVirology 1998; 4:394-406.
Olin P, Giesecke J. Potential exposure to
SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates
1960 to 1993. Dev Biol Stand. 1998, 94:227-33.
Rizzo P, Resta ID, Powers A, Ratner H,
Carbone M. Unique strains of SV40 in commercial poliovaccines from 1955 not readily
identifiable with current testing for SV40 infection. Cancer Research 1999;59:6103-6108.
Shah K, Nathanson N. Human exposure to
SV40: Reviews and Comment.. Am J Epidemiol 1976, 103:11-12.
Sherwood RW, Buescher EL, Nitz RE et al.
Effects of adenovirus vaccine in acute respiratory disease in US Army recruits. JAMA 1961,
178:1125-1127.
Shivapurkar N, Harada K, Reddy J,
Scheuermann RH, Xu Y, et al. Presence of simian virus 40 DNA sequences in human lymphomas.
Lancet 2002 359:851-852.
Sierra Honigmann A, Krause PR. Live oral
poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA. Biologicals
2000, 28(1):1-4.
Strickler HD, Rosenberg PS, Devesa SS,
Hertel J, Fraumeni JF, Goedert JJ. Contamination of poliovirus vaccines with simian virus
40 (1955-1963) and subsequent cancer rates. JAMA, January 28, 1998; 279(4):292-295.
Strickler HD, Goedert JJ. Exposure to S40
contaminated poliovirus vaccine and the risk of cancer-A review of the epidemiological
evidence. In F Brown and AM Lewis (eds.) Simian Virus 40 (SV40): A possible human
polyomavirus. Dev Bio Stand Basel Karger 1998, 94:235-244.
Vilchez RA, Madden CR, Kozinetz CA,
Halvorson SJ, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet
2002, 359: 817-823.
Zimmermann W, Scherneck S, Geissler E.
Quantitative determination of papovavirus IgG antibodies in sera from cancer patients,
labworkers and several groups of control persons by enzyme-linked immunosorbent assay
(ELISA). Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene-1-Abt-Originale A,
Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie 1983, 254:187-96.
